NIH Ethics Guidelines Draw Hostile Response

WASHINGTON—In a document that is being roundly condemned by science administrators, lobbyists, and other observers, the National Institutes of Health has proposed vol- untary guidelines on financial conflicts of interest by university researchers. The criticism from experts in the field is expected to sharpen the explosive debate on how to preserve the integrity of federally funded research while at the same time translating that research into products that are designed to improve publi

Written byJeffrey Mervis
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

WASHINGTON—In a document that is being roundly condemned by science administrators, lobbyists, and other observers, the National Institutes of Health has proposed vol- untary guidelines on financial conflicts of interest by university researchers.

The criticism from experts in the field is expected to sharpen the explosive debate on how to preserve the integrity of federally funded research while at the same time translating that research into products that are designed to improve public health.

The guidelines appear in the September 15 issue of the NIH Guide for Grants and Contracts (vol 18, no. 32). They apply to any research funded by NIH or the Alcohol, Drug Abuse, and Mental Health Administration (ADAMHA). Under the proposal, universities and other recipients of federal funds are advised to draw up policies to monitor potential conflicts of interest by faculty and other employees that could distort the conduct or results of such research.

The ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies